iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
7.42
+0.20 (2.77%)
At close: Dec 20, 2024, 4:00 PM
7.45
+0.03 (0.41%)
After-hours: Dec 20, 2024, 7:29 PM EST
iTeos Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 271 | 392 | 695 | 1,642 | 1,185 | - | |
| Market Cap Growth | -4.83% | -43.60% | -57.70% | 38.57% | - | - | |
| Enterprise Value | -212 | -201 | -53 | 745 | 845 | - | |
| Last Close Price | 7.42 | 10.95 | 19.53 | 46.56 | 33.82 | - | |
| PE Ratio | - | - | 7.19 | 7.66 | - | - | |
| Forward PE | - | - | - | 10.82 | - | - | |
| PS Ratio | 8.19 | 31.11 | 2.60 | 4.76 | - | - | |
| PB Ratio | 0.43 | 0.68 | 1.05 | 2.97 | 3.67 | - | |
| P/TBV Ratio | 0.59 | 0.68 | 1.05 | 2.97 | 3.67 | - | |
| P/FCF Ratio | - | - | - | 3.21 | - | - | |
| P/OCF Ratio | - | - | - | 3.20 | - | - | |
| EV/Sales Ratio | - | - | - | 2.16 | - | - | |
| EV/EBITDA Ratio | - | - | - | 3.04 | - | - | |
| EV/EBIT Ratio | - | - | - | 3.04 | - | - | |
| EV/FCF Ratio | - | - | - | 1.46 | - | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | - | - | |
| Debt / EBITDA Ratio | - | - | 0.04 | 0.02 | - | - | |
| Debt / FCF Ratio | - | - | - | 0.01 | - | - | |
| Asset Turnover | 0.05 | 0.02 | 0.33 | 0.56 | - | - | |
| Quick Ratio | 14.44 | 13.46 | 14.66 | 2.83 | 22.45 | 1.91 | |
| Current Ratio | 14.80 | 13.76 | 14.96 | 2.88 | 22.64 | 1.98 | |
| Return on Equity (ROE) | -19.72% | -18.19% | 15.89% | 48.98% | -22.45% | -146.18% | |
| Return on Assets (ROA) | -13.04% | -12.97% | 9.72% | 24.90% | -14.97% | -58.61% | |
| Return on Capital (ROIC) | -14.71% | -14.77% | 13.00% | 34.73% | -16.58% | -110.91% | |
| Earnings Yield | -44.73% | -28.75% | 13.91% | 13.06% | -3.21% | - | |
| FCF Yield | -44.39% | -27.24% | -16.14% | 31.17% | -2.15% | - | |
| Buyback Yield / Dilution | -8.15% | 5.30% | 0.02% | -150.49% | -7336.29% | -9.20% | |
| Total Shareholder Return | -8.15% | 5.30% | 0.02% | -150.49% | -7336.29% | -9.20% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.